About OncoLens
OncoLens is a company based in Atlanta (United States) founded in 2015 by Anju Mathew. OncoLens has raised $27.1 million across 4 funding rounds from investors including Atlanta Technology Angels, BIP Ventures and Cross-Border Impact Ventures. The company has 35 employees as of December 31, 2023. OncoLens offers products and services including OncoLens Platform, Molecular Store, Integrate Module, and Collaborate Module. OncoLens operates in a competitive market with competitors including Medshr, F6S Network, Omnidoc, Liangyihui and Curofy, among others.
- Headquarter Atlanta, United States
- Employees 35 as on 31 Dec, 2023
- Founders Anju Mathew
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Lynkcare, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$27.1 M (USD)
in 4 rounds
-
Latest Funding Round
$16 M (USD), Series B
Oct 02, 2024
-
Investors
Atlanta Technology Angels
& 4 more
-
Employee Count
35
as on Dec 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of OncoLens
OncoLens offers a comprehensive portfolio of products and services, including OncoLens Platform, Molecular Store, Integrate Module, and Collaborate Module.
Integrates data for precise cancer treatment and collaboration
Stores biomarkers for research and treatment recommendations
Connects EMR systems for real-time patient information
Enables real-time team discussions on cancer cases
People of OncoLens
Unlock access to complete
Unlock access to complete
Funding Insights of OncoLens
OncoLens has successfully raised a total of $27.1M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $16 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in OncoLens
OncoLens has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Atlanta Technology Angels, BIP Ventures and Cross-Border Impact Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are provided by BIP Ventures.
|
Locked | Locked | Locked | |
|
Investments are focused on health technology for global impact.
|
Locked | Locked | Locked | |
|
Early-stage tech focused VC firm investing in geographies such as the US
|
Locked | Locked | Locked |
Investor details for OncoLens
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by OncoLens
Investment portfolio details for OncoLens
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - OncoLens
Detailed financials for OncoLens
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Oncolens Comparisons
Peer comparison for OncoLens
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of OncoLens
OncoLens operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Medshr, F6S Network, Omnidoc, Liangyihui and Curofy, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Knowledge sharing platform for Physicians
|
|
| Locked | Locked | Locked |
Provider of platforms for startups to find investors, talent and other resources
|
|
| Locked | Locked | Locked |
Provider of social discussion platform for physicians
|
|
| Locked | Locked | Locked |
Medical information platform for cancer
|
|
| Locked | Locked | Locked |
Online network for doctors' communication and patient referrals is provided.
|
Detailed competitors of OncoLens
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Oncolens
Complete news archive for OncoLens
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about OncoLens
OncoLens was founded in 2015 and raised its 1st funding round 4 years after it was founded.
OncoLens is headquartered in Atlanta, United States. It is registered at Atlanta, Georgia, United States.
Anju Mathew is the current CEO of OncoLens. They have also founded this company.
OncoLens is a funded company, having raised a total of $27.1M across 4 funding rounds to date.
As of Dec 31, 2023, the latest employee count at OncoLens is 35.
OncoLens is a HIPAA compliant mobile and web-based platform for connecting oncologists. The platform enables physicians to create a tumor board and also allows them and other care providers to discuss and develop treatment plans for their cancer patients in real-time. OncoLens also enables the discussion of cases among colleagues and care teams without the involvement of a tumor board. Through the engagement of clinical trial researchers, cases can be identified early on as potential candidates for clinical trials.
OncoLens's top competitors include F6S Network, Curofy and Medshr.
OncoLens offers OncoLens Platform, Molecular Store, Integrate Module, and Collaborate Module.
OncoLens has 5 investors. Key investors include Atlanta Technology Angels, BIP Ventures, Cross-Border Impact Ventures, Martin Ventures, and seedToB.